A Mutation in the Promoter of the Multidrug Resistance Gene (MDR1) in Human Hematological Malignancies may Contribute to the Pathogenesis of Resistant Disease-Reference-Cited by-同舟云学术

A Mutation in the Promoter of the Multidrug Resistance Gene (MDR1) in Human Hematological Malignancies may Contribute to the Pathogenesis of Resistant Disease

Published:1999 Issue: Volume: Page:71-75
ISSN:0065-2598
Container-title:Drug Resistance in Leukemia and Lymphoma III
language:
Short-container-title:

Author:

Rund Deborah,Azar Idit,Shperling Olga

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4615-4811-9_9

Reference18 articles.

1. Pastan I, Gottesman M: Multidrug resistance. Ann Rev Med 1991;42:277–286

2. Simon S, Schindler M: Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91:3497–3504, 1994

3. Jones P: DNA methylation errors and cancer. Cancer Research 1996;56:2463–2467

4. Stein U, Walther W, Wunderlich V: Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Euro J Cancer 1994;30A: 1541–1545

5. Chaudhary P, Roninson I: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85–94

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer;Trends in Cancer;2021-04

2. Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?;Cellular Signalling;2017-10

3. Different frequencies and effects of ABCB1 T3435C polymorphism on clinical and laboratory features of B cell chronic lymphocytic leukemia in Kurdish patients;Tumor Biology;2015-01-15

4. Progressive course of isolated splenic myeloid sarcoma;Open Medicine;2013-08-01

5. Oxidative stress in oncohematologic diseases: an update;Expert Review of Hematology;2013-06